|
1
|
Feigin VL, Brainin M, Norrving B, Martins
SO, Pandian J, Lindsay P, F Grupper M and Rautalin I: World stroke
organization: Global stroke fact sheet 2025. Int J Stroke.
20:132–144. 2025.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Liu D, Ji Q, Cheng Y, Liu M, Zhang B, Mei
Q, Huan M and Zhou S: Cyclosporine A loaded brain targeting
nanoparticle to treat cerebral ischemia/reperfusion injury in mice.
J Nanobiotechnology. 20(256)2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Guo XB, Deng X, Wang J, Qi Y, Zhao W and
Guan S: HAX-1 interferes in assembly of NLRP3-ASC to block
microglial pyroptosis in cerebral I/R injury. Cell Death Discov.
10:1–13. 2024.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zhang C, Ma Y, Zhao Y, Guo N, Han C, Wu Q,
Mu C, Zhang Y, Tan S, Zhang J and Liu X: Systematic review of
melatonin in cerebral ischemia-reperfusion injury: Critical role
and therapeutic opportunities. Front Pharmacol.
15(1356112)2024.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Wang K, Zhao H, Chen J, Yan LL, Zhao B,
Chen Y, Dong YY, Li ZC and He Z: Toona sinensis fruit polyphenols
alleviate cerebral ischemia-reperfusion injury in rats by
inhibiting MAPK signaling pathways and NLRP3
inflammasome/pyroptosis. J Ethnopharmacol.
342(119375)2025.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Gao P, Shi H, Jin X, Guo S, Zhou X and Gao
W: Mechanism of astragaloside IV regulating NLRP3 through
LOC102555978 to attenuate cerebral ischemia reperfusion induced
microglia pyroptosis. Int Immunopharmacol.
131(111862)2024.PubMed/NCBI View Article : Google Scholar
|
|
7
|
He C, Zhao Y, Jiang X, Liang X, Yin L, Yin
Z, Geng Y, Zhong Z, Song X, Zou Y, et al: Protective effect of
Ketone musk on LPS/ATP-induced pyroptosis in J774A.1 cells through
suppressing NLRP3/GSDMD pathway. Int Immunopharmacol. 71:328–335.
2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Liu Y, Lei H, Zhang W, Xing Q, Liu R, Wu
S, Liu Z, Yan Q, Li W, Liu X and Hu Y: Pyroptosis in renal
inflammation and fibrosis: Current knowledge and clinical
significance. Cell Death Dis. 14(472)2023.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Li J, Teng D, Jia W, Gong L, Dong H, Wang
C, Zhang L, Xu B, Wang W, Zhong L, et al: PLD2 deletion ameliorates
sepsis-induced cardiomyopathy by suppressing cardiomyocyte
pyroptosis via the NLRP3/caspase 1/GSDMD pathway. Inflamm Res.
73:1033–1046. 2024.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Pinna A, Parekh P and Morelli M: Serotonin
5-HT1A receptors and their interactions with adenosine A2A
receptors in Parkinson's disease and dyskinesia. Neuropharmacology.
226(109411)2023.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Khan H, Kaur P, Singh TG, Grewal AK and
Sood S: Adenosine as a key mediator of neuronal survival in
cerebral ischemic injury. Neurochem Res. 47:3543–3555.
2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Shi Y, Dai Q, Ji B, Huang L, Zhuang X, Mo
Y and Wang J: Electroacupuncture pretreatment prevents cognitive
impairment induced by cerebral ischemia-reperfusion via adenosine
A1 receptors in rats. Front Aging Neurosci.
13(680706)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Li MZ, Zhao Y, Dai XY, Talukder M and Li
JL: Lycopene ameliorates DEHP exposure-induced renal pyroptosis
through the Nrf2/Keap-1/NLRP3/caspase-1 axis. J Nutr Biochem.
113(109266)2023.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Fabera P, Parizkova M, Uttl L, Vondrakova
K, Kubova H, Tsenov G and Mares P: Adenosine A1 receptor agonist
2-chloro-N6-cyclopentyladenosine and hippocampal excitability
during brain development in rats. Front Pharmacol.
10(656)2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Geng W, Cai L, Han K, Li D, Mo Y, Dai Q,
Tang H, Zhang M, Akuetteh PDP, Balelang MF and Wang J:
Electroacupuncture pretreatment alleviates cerebral
ischemia-reperfusion injury by increasing GSK-3β phosphorylation
level via adenosine a1 receptor. BioMed Res Int.
2020(6848450)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Fan GB, Li Y, Xu GS, Zhao AY, Jin HJ, Sun
SQ and Qi SH: Propofol inhibits ferroptotic cell death through the
Nrf2/Gpx4 signaling pathway in the mouse model of cerebral
ischemia-reperfusion injury. Neurochem Res. 48:956–966.
2023.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Chen L, Huang J, Yao ZM, Sun XR, Tong XH,
Hu M, Zhang Y and Dong SY: Procyanidins alleviated cerebral
ischemia/reperfusion injury by inhibiting ferroptosis via the
Nrf2/HO-1 signaling pathway. Molecules. 28(3582)2023.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Liu H, Li J, Jiang L, He J, Zhang H and
Wang K: Dexmedetomidine pretreatment alleviates cerebral
ischemia/reperfusion injury by inhibiting neuroinflammation through
the JAK2/STAT3 pathway. Braz J Med Biol Res.
55(e12145)2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Longa EZ, Weinstein PR, Carlson S and
Cummins R: Reversible middle cerebral artery occlusion without
craniectomy in rats. Stroke. 20:84–91. 1989.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Han W, Zhang E, Tian Y, Wang S and Chen Y:
Reversible middle cerebral artery occlusion without craniectomy in
rats. Exp Brain Res. 241:1471–1488. 2023.
|
|
21
|
Ramos-Zepeda G and Herrero JF: Interaction
of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA)
and opioid receptors in spinal cord nociceptive reflexes. Life Sci.
93:233–239. 2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Liu H, Sun Q, Ding Z, Shi W, Wang WH and
Zhang C: Adenosine stimulates the basolateral 50 pS K+ channel in
renal proximal tubule via adenosine-A1 receptor. Front Physiol.
14(1242975)2023.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Schädlich IS, Winzer R, Stabernack J,
Tolosa E, Magnus T and Rissiek B: The role of the ATP-adenosine
axis in ischemic stroke. Semin Immunopathol. 45:347–365.
2023.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Martire A, Lambertucci C, Pepponi R,
Ferrante A, Benati N, Buccioni M, Dal Ben D, Marucci G, Klotz KN,
Volpini R and Popoli P: Neuroprotective potential of adenosine A1
receptor partial agonists in experimental models of cerebral
ischemia. J Neurochem. 149:211–230. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Martí Navia A, Dal Ben D, Lambertucci C,
Spinaci A, Volpini R, Marques-Morgado I, Coelho JE, Lopes LV,
Marucci G and Buccioni M: Adenosine receptors as neuroinflammation
modulators: Role of A1 Agonists and A2A Antagonists. Cells.
9(1739)2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Liu J, Wang X, Wang X, Wang J, Ma Y, Cao Y
and Zhang W: Chicken gasdermins mediate pyroptosis after the
cleavage by caspases. Int J Biol Macromol.
270(132476)2024.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Luo E, Li Z, Zhang S, Wen Y, Yang Z, Zeng
H and Ding H: Hyperglycemia induces microglial pyroptosis by
increasing oxygen extraction rate: Implication in neurological
impairment during ischemic stroke. Mol Med Rep.
30(146)2024.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Tuo QZ, Zhang ST and Lei P: Mechanisms of
neuronal cell death in ischemic stroke and their therapeutic
implications. Med Res Rev. 42:259–305. 2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Tastan B, Arioz BI and Genc S: Targeting
NLRP3 inflammasome with Nrf2 inducers in central nervous system
disorders. Front Immunol. 13(865772)2022.PubMed/NCBI View Article : Google Scholar
|
|
30
|
She Y, Shao L, Jiao K, Sun R, Lang T, Long
H, Tang Y, Zhang W, Ding C and Deng C: Glycosides of Buyang Huanwu
decoction inhibits pyroptosis associated with cerebral
ischemia-reperfusion through Nrf2-mediated antioxidant signaling
pathway both in vivo and in vitro. Phytomedicine.
120(155001)2023.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Cheng Y, Cheng L, Gao X, Chen S, Wu P,
Wang C and Liu Z: Covalent modification of Keap1 at Cys77 and
Cys434 by pubescenoside a suppresses oxidative stress-induced NLRP3
inflammasome activation in myocardial ischemia-reperfusion injury.
Theranostics. 11:861–877. 2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Shi M, Wang J, Bi F and Bai Z: Diosmetin
alleviates cerebral ischemia-reperfusion injury through
Keap1-mediated Nrf2/ARE signaling pathway activation and NLRP3
inflammasome inhibition. Environ Toxicol. 37:1529–1542.
2022.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Liston TE, Hama A, Boltze J, Poe RB,
Natsume T, Hayashi I, Takamatsu H, Korinek WS and Lechleiter JD:
Adenosine A1R/A3R (adenosine A1 and A3 receptor) agonist AST-004
reduces brain infarction in a nonhuman primate model of stroke.
Stroke. 53:238–248. 2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zhong M, Song WL, Xu YC, Ye Y and Feng LY:
Paeoniflorin ameliorates ischemic neuronal damage in vitro via
adenosine A1 receptor-mediated transactivation of epidermal growth
factor receptor. Acta Pharmacol Sin. 36:298–310. 2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Rabie MA, Ibrahim HI, Nassar NN and Atef
RM: Adenosine A1 receptor agonist, N6-cyclohexyladenosine,
attenuates Huntington's disease via stimulation of
TrKB/PI3K/Akt/CREB/BDNF pathway in 3-nitropropionic acid rat model.
Chem Biol Interact. 369(110288)2023.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Guo Y, Mao M, Li Q, Yu X and Zhou L:
Extracts of Ginkgo flavonoids and ginkgolides improve cerebral
ischaemia-reperfusion injury through the PI3K/Akt/Nrf2 signalling
pathway and multicomponent in vivo processes. Phytomedicine.
99(154028)2022.PubMed/NCBI View Article : Google Scholar
|
